Chengping Hu

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Allergic Rhinitis

Immune Response

Bariatric Surgery

Vascular Endothelial Growth Factor

Top Venues

Cancer medicine

Molecular medicine (Cambridge, Mass.)

This page only lists publications with an associated author ORCID identifier.

Publications

Yang Wang, Rongjun Wan, Chengping Hu
Leptin/obR signaling exacerbates obesity-related neutrophilic airway inflammation through inflammatory M1 macrophages. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Yang Wang, Chengping Hu
Leptin and Asthma: What Are the Interactive Correlations? Biomolecules 12 (12) (2022)
Yang Wang, Chengping Hu
Leptin and Asthma: What Are the Interactive Correlations? Biomolecules 12 (12) (2022)
Bo Peng Deng, Chengping Hu, Cen Chen, Liming Cao, Qihua Gu, Jian An, Ling Qin, Min Li, Baimei He, Juan Jiang, Huaping Yang
Anlotinib plus platinum-etoposide as a first-line treatment for extensive-stage small cell lung cancer: A single-arm trial. Cancer medicine 11 (19) (2022)
Yang Wang, Chengping Hu
Leptin and Asthma: What Are the Interactive Correlations? Biomolecules 12 (12) (2022)
Yang Wang, Chengping Hu
Leptin and Asthma: What Are the Interactive Correlations? Biomolecules 12 (12) (2022)
Dongjing Cai, Chengping Hu, Li Li, Shichao Deng, Jing Yang, Han Han-Zhang, Min Li
The prevalence and prognostic value of KRAS co-mutation subtypes in Chinese advanced non-small cell lung cancer patients. Cancer medicine 9 (1) (2019)